Taro to Release Third Quarter Results on January 25, 2024

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it plans to release its financial results for the third quarter ended December 31, 2023, after the close of market on Thursday, January 25, 2024.

The release will be accessible on Taro’s website at www.taro.com.

About Taro

Taro Pharmaceutical Industries Ltd. is a multinational, science-based pharmaceutical company, dedicated to meeting the needs of its customers through the discovery, development, manufacturing and marketing of the highest quality healthcare products. For further information on Taro Pharmaceutical Industries Ltd., please visit the Company’s website at www.taro.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240119038585/en/

The Taro Pharmaceutical Industries Stock at the time of publication of the news with a fall of -0,26 % to 38,70EUR on Lang & Schwarz stock exchange (19. Januar 2024, 22:17 Uhr).